Pulse Biosciences (PLSE) Competitors $17.31 +0.52 (+3.10%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$17.66 +0.35 (+2.02%) As of 08/14/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. INSP, NVST, PRCT, WRBY, LIVN, EYE, LMAT, CNMD, LQDA, and ENOVShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Liquidia Technologies (LQDA), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. Its Competitors Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision LeMaitre Vascular CONMED Liquidia Technologies Enovis Inspire Medical Systems (NYSE:INSP) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability. Which has preferable valuation & earnings, INSP or PLSE? Inspire Medical Systems has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M3.12$53.51M$1.7348.95Pulse Biosciences$700K1,663.74-$53.58MN/AN/A Do analysts prefer INSP or PLSE? Inspire Medical Systems presently has a consensus target price of $173.31, suggesting a potential upside of 104.66%. Pulse Biosciences has a consensus target price of $22.00, suggesting a potential upside of 27.09%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, INSP or PLSE? Inspire Medical Systems has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500. Do insiders & institutionals have more ownership in INSP or PLSE? 94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer INSP or PLSE? In the previous week, Inspire Medical Systems had 23 more articles in the media than Pulse Biosciences. MarketBeat recorded 30 mentions for Inspire Medical Systems and 7 mentions for Pulse Biosciences. Inspire Medical Systems' average media sentiment score of 0.53 beat Pulse Biosciences' score of 0.21 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 10 Very Positive mention(s) 1 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Is INSP or PLSE more profitable? Inspire Medical Systems has a net margin of 6.17% compared to Pulse Biosciences' net margin of 0.00%. Inspire Medical Systems' return on equity of 10.38% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.17% 10.38% 8.93% Pulse Biosciences N/A -63.19%-54.98% SummaryInspire Medical Systems beats Pulse Biosciences on 11 of the 15 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13B$7.00B$5.61B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-16.4925.4830.2925.74Price / Sales1,663.7473.48463.41115.83Price / CashN/A21.9738.2159.48Price / Book11.175.388.826.15Net Income-$53.58M$176.29M$3.25B$265.06M7 Day Performance17.68%3.21%3.70%2.60%1 Month Performance13.73%1.49%5.84%2.83%1 Year Performance-9.32%10.20%29.92%25.58% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences3.8326 of 5 stars$17.31+3.1%$22.00+27.1%+2.9%$1.13B$700K-16.49140News CoverageEarnings ReportHigh Trading VolumeINSPInspire Medical Systems4.9013 of 5 stars$130.79+3.7%$208.55+59.5%-55.5%$3.72B$802.80M60.271,246Buyback AnnouncementShort Interest ↓High Trading VolumeNVSTEnvista3.5249 of 5 stars$20.48-1.7%$20.92+2.2%+20.4%$3.46B$2.51B63.9912,300PRCTPROCEPT BioRobotics3.0924 of 5 stars$49.60-0.7%$84.13+69.6%-37.9%$2.76B$249.12M-29.18430WRBYWarby Parker2.0777 of 5 stars$24.47+3.7%$23.13-5.5%+110.1%$2.47B$771.32M-203.883,780News CoverageInsider TradeLIVNLivaNova1.3395 of 5 stars$42.76+4.0%$59.29+38.6%+18.8%$2.24B$1.25B-10.452,900EYENational Vision2.6771 of 5 stars$25.07+3.6%$24.18-3.5%+119.6%$1.91B$1.82B-75.9713,411LMATLeMaitre Vascular2.1303 of 5 stars$84.36+4.1%$97.83+16.0%+16.8%$1.83B$226.26M42.61490Insider TradeCNMDCONMED4.2627 of 5 stars$53.46+2.2%$59.80+11.9%-21.4%$1.62B$1.31B15.153,900Dividend AnnouncementLQDALiquidia Technologies3.5214 of 5 stars$19.48+10.2%$26.89+38.0%+89.9%$1.51B$14M-12.3350Trending NewsEarnings ReportAnalyst ForecastOptions VolumeENOVEnovis3.9041 of 5 stars$26.61+3.4%$55.60+109.0%-32.9%$1.47B$2.11B-1.917,367 Related Companies and Tools Related Companies INSP Competitors NVST Competitors PRCT Competitors WRBY Competitors LIVN Competitors EYE Competitors LMAT Competitors CNMD Competitors LQDA Competitors ENOV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access